AQUINOX PHARMACEUTICALS INC — Form D

AQUINOX PHARMACEUTICALS INC of RICHMOND, A1, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-02. The offering totals $39, of which $26 was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Kenneth GalbraithDirectorVancouver, A1
Dr. Elain JonesDirectorRichmond, A1
Dr. Daniel LevinDirectorRichmond, A1
David MainDirectorVancouver, A1
Dr. Asish XavierDirectorRichmond, A1
Kamran AlamExecutive OfficerRichmond, A1
Dr. Thomas MacRuryExecutive OfficerRichmond, A1
David MainExecutive OfficerVancouver, A1
Dr. Elaine J JonesDirectorRichmond, A1
Dr. Asish J XavierDirectorRichmond, A1
Frank J HollerDirectorRichmond, A1
Kamran J AlamExecutive OfficerRichmond, A1
Kenneth J GalbraithDirectorRichmond, A1
David J MainDirectorRichmond, A1
David J MainExecutive OfficerRichmond, A1
David J MainPromoterRichmond, A1
Dr. Thomas J MacRuryExecutive OfficerRichmond, A1
Dr. Daniel J LevittDirectorRichmond, A1
Frank H HollerDirectorVancouver, A1
Kenneth H GalbraithDirectorVancouver, A1
Elaine H JonesDirectorNew York, NY
Csaba H SzaboExecutive OfficerRichmond, A1
Asish H XavierDirectorNew Brunswick, NJ
Daniel H LevittDirectorRichmond, A1
David H ChernoffExecutive OfficerRichmond, A1

Other filings by this issuer (4)

FiledFormOfferingSold
2011-09-26D$6$6
2011-02-11D$9$9
2010-06-25D$6$6
2010-04-16D$9$9

More